Yale researchers use lupus antibody to possibly treat glioblastoma
Researchers at Yale Cancer Center have made a breakthrough finding that could lead to a therapies for glioblastoma and other ...
Scinai signs an option agreement to acquire rare disease company Pincell and its novel antibody for treating Severe Dermatological Conditions
Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), a biopharmaceutical company specializing in inflammation and immunology (I&I) ...
Lupus-related antibody shows promise in enhancing cancer treatment efficacy
Yale scientists have discovered a promising way to trigger immune responses against certain tumors, using a lupus-related ...
Antibody-based therapy is several steps closer to treat lethal mucormycosis
Mucormycosis, a fungal infection caused by Mucorales, has high mortality rates in people with weakened immune systems and ...
Cantargia Presents Promising Preclinical Results on a Novel IL1RAP-Targeting Antibody-Drug Conjugate at AACR 2025
Cantargia (Cantargia AB (publ); Nasdaq Stockholm:CANTA) today announced an upcoming presentation of preclinical data on the ...
The Manila Times1d
Zymeworks to Present Preclinical Data on T cell Engager and Antibody-Drug Conjugate Platforms in Six Posters at AACR Annual Meeting
Novel trispecific T cell engager, ZW209, demonstrates potent preclinical efficacy against DLL3-expressing tumors and an ...
News Medical on MSN3d
Study reveals new antibody treatment for flesh eating fungus infection
A new study offers hope in the fight against flesh-eating fungus infections. Researchers have discovered a promising antibody ...
News-Medical.Net on MSN17h
Fusion proteins enable the creation of monoclonal antibodies
The Food and Drug Administration has approved more than 100 monoclonal antibodies to treat a range of diseases. Other antibodies are used by physicians to diagnose conditions or by scientists to ...